The influence of the human microbiome and probiotics on cardiovascular health

Gut Microbes

Volumn 5, Issue 6, 2014, Pages 719-728

  Ettinger, Grace ^a,b   MacDonald, Kyle ^a,b   Reid, Gregor ^a,b   Burton, Jeremy P ^a,b  

^a LAWSON HEALTH RESEARCH INSTITUTE   (Canada)

^b UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

Cardioprotection; Cardiovascular disease; Dysbiosis; Microbiome; Periodontal disease; Probiotics

Indexed keywords

C REACTIVE PROTEIN; CARNITINE; CHOLESTEROL; CONJUGATED LINOLEIC ACID; FARNESOID X RECEPTOR; INTERLEUKIN 6; NITRATE; PROBIOTIC AGENT; TRIMETHYLAMINE OXIDECARNITINE; UNCLASSIFIED DRUG;

ACTINOBACTERIA; ARTERIOSCLEROSIS; ATHEROSCLEROTIC PLAQUE; BACTERIAL STRAIN; BACTEROIDETES; BIFIDOBACTERIUM; CARDIOVASCULAR DISEASE; CLOSTRIDUM DIFFICILE; CONTROLLED CLINICAL TRIAL (TOPIC); DIET; FIRMICUTES; FUSOBACTERIA; HEART FAILURE; HEART INFARCTION; HELICOBACTER PYLORI; HUMAN; HYPERTENSION; INTESTINE FLORA; ISCHEMIC HEART DISEASE; LACTOBACILLUS PLANTARUM; LACTOBACILLUS REUTERI; LACTOBACILLUS RHAMNOSUS; LACTOBACILLUS SAKEI; META ANALYSIS (TOPIC); MICROBIOME; MOUTH FLORA; NONHUMAN; OBESITY; PERIODONTAL DISEASE; PORPHYROMONAS GINGIVALIS; PREVOTELLA; PROTEOBACTERIA; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; STREPTOCOCCUS PYOGENES; CARDIOVASCULAR DISEASES; GASTROINTESTINAL TRACT; METABOLISM; MICROBIOLOGY; MICROFLORA;

BACTERIA (MICROORGANISMS);

CARDIOVASCULAR DISEASES; GASTROINTESTINAL TRACT; HUMANS; MICROBIOTA; PROBIOTICS;

EID: 84922042162     PISSN: 19490976     EISSN: 19490984     Source Type: Journal    
DOI: 10.4161/19490976.2014.983775     Document Type: Review

References (120)

1. Human Microbiome Project Consortium. Structure, function and diversity of the healthy human microbiome. Nature 2012; 486:207-214; PMID:22699609; http://dx. doi.org/10.1038/nature11234
2. Cho I, Blaser MJ. The human microbiome: At the interface of health and disease. Nat Rev Genet 2012; 13:260-270; PMID:22411464
3. Turnbaugh PJ, Ley RE, Hamady M, Fraser-Liggett CM, Knight R, Gordon JI. The human microbiome project. Nature 2007; 449:804-810; PMID: 17943116; http://dx.doi.org/10.1038/nature06244
4. Hamady M, Knight R. Microbial community profiling for human microbiome projects: Tools, techniques, and challenges. Genome Res 2009; 19:1141- 1152; PMID:19383763; http://dx.doi.org/10.1101/ gr.085464.108
5. Eckburg PB, Bik EM, Bernstein CN, Purdom E, Dethlefsen L, Sargent M, Gill SR, Nelson KE, Relman DA. Diversity of the human intestinal microbial flora. Science 2005; 308:1635-1638; PMID:15831718; http://dx.doi.org/10.1126/science. 1110591
6. Ley RE, Turnbaugh PJ, Klein S, Gordon JI. Microbial ecology: Human gut microbes associated with obesity. Nature2006; 444:1022-1023; PMID:17183309; http://dx.doi.org/10.1038/4441022a
7. Tremaroli V, Backhed F. Functional interactions between the gut microbiota and host metabolism. Nature 2012; 489:242-249; PMID:22972297; http:// dx.doi.org/10.1038/nature11552
8. Mendis S, Puska P, Norrving B. Global atlas on cardiovascular disease prevention and control. World Health Organization, World Heart Federation, World Stroke Organization 2011; ISBN 978-92-4-156437-3
9. Dewhirst FE, Chen T, Izard J, Paster BJ, Tanner AC, Yu WH, Lakshmanan A, Wade WG. The human oral microbiome. J Bacteriol 2010; 192:5002-5017; PMID:20656903; http://dx.doi. org/10.1128/JB.00542-10
10. Zaura E, Keijser BJ, Huse SM, Crielaard W. Defining the healthy "core microbiome" of oral microbial communities. BMC Microbiol 2009; 9:259-2180-9-259; PMID:19144191; http://dx.doi.org/10.1186/1471- 2180-9-259
11. Marsh P. Role of the oral microflora in health. Microb Ecol Health Dis 2000; 12:130-137; http://dx.doi.org/ 10.1080/089106000750051800
12. Marijon E, Mirabel M, Celermajer DS, Jouven X. Rheumatic heart disease. Lancet 2012; 379:953-964; PMID:22405798; http://dx.doi.org/10.1016/S0140- 6736(11)61171-9
13. Bessen DE. Population biology of the human restricted pathogen, Streptococcus pyogenes. Infect Genet Evol 2009; 9:581-593; PMID:19460325; http://dx.doi.org/10.1016/j.meegid.2009.03.002
14. Desvarieux M, Demmer RT, Jacobs DR, Papapanou PN, Sacco RL, Rundek T. Changes in clinical and microbiological periodontal profiles relate to progression of carotid intima-media thickness: The oral infections and vascular disease epidemiology study. J Am Heart Assoc 2013; 2:e000254; PMID:24166489; http://dx.doi.org/10.1161/JAHA.113.000254
15. Mustapha IZ, Debrey S, Oladubu M, Ugarte R. Markers of systemic bacterial exposure in periodontal disease and cardiovascular disease risk: A systematic review and meta-analysis. J Periodontol 2007; 78:2289-2302; PMID:18052701; http://dx.doi.org/ 10.1902/jop.2007.070140
16. Dietrich T, Sharma P, Walter C, Weston P, Beck J. The epidemiological evidence behind the association between periodontitis and incident atherosclerotic cardiovascular disease. J Clin Periodontol 2013; 40 Suppl 14:S70-84
17. Lockhart PB, Bolger AF, Papapanou PN, Osinbowale O, Trevisan M, Levison ME, Taubert KA, Newburger JW, Gornik HL, Gewitz MH, et al. American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee of the Council on Cardiovascular Disease in the Young, Council on Epidemiology and Prevention, Council on Peripheral Vascular Disease, and Council on Clinical Cardiology. Periodontal disease and atherosclerotic vascular disease: Does the evidence support an independent association? A scientific statement from the American heart association. Circulation 2012; 125:2520-2544; PMID:22514251; http://dx.doi.org/10.1161/CIR. 0b013e31825719f3
18. Teles R, Wang CY. Mechanisms involved in the association between periodontal diseases and cardiovascular disease. Oral Dis 2011; 17:450-461; PMID:21223455; http://dx.doi.org/10.1111/j.1601- 0825.2010.01784.x
19. Darveau RP. Periodontitis: A polymicrobial disruption of host homeostasis. Nat Rev Microbiol 2010; 8:481-490; PMID:20514045; http://dx.doi.org/ 10.1038/nrmicro2337
20. Haraszthy VI, Zambon JJ, Trevisan M, Zeid M, Genco RJ. Identification of periodontal pathogens in atheromatous plaques. J Periodontol 2000; 71:1554- 1560; PMID:11063387; http://dx.doi.org/10.1902/ jop.2000.71.10.1554
21. Ott SJ, El Mokhtari NE, Musfeldt M, Hellmig S, Freitag S, Rehman A, Kühbacher T, Nikolaus S, Namsolleck P, Blaut M, et al. Detection of diverse bacterial signatures in atherosclerotic lesions of patients with coronary heart disease. Circulation 2006; 113:929-937; PMID:16490835; http://dx.doi. org/10.1161/CIRCULATIONAHA.105.579979
22. Koren O, Spor A, Felin J, Fåk F, Stombaugh J, Tremaroli V, Behre CJ, Knight R, Fagerberg B, Ley RE, et al. Human oral, gut, and plaque microbiota in patients with atherosclerosis. Proc Natl Acad Sci U S A 2011; 108 Suppl 1:4592-4598; PMID:20937873; http://dx.doi.org/10.1073/pnas.1011383107
23. Ford PJ, Gemmell E, Hamlet SM, Hasan A, Waler PJ, West MJ, Cullinan MP, Seymour GJ. Cross-reactivity of GroEL antibodies with human heat shock protein 60 and quantification of pathogens in atherosclerosis. Oral Microbiol Immunol 2005; 20:296-302; PMID:16101965; http://dx.doi.org/10.1111/j.1399- 302X.2005.00230.x
24. Metzler B, Schett G, Kleindienst R, van der Zee R, Ottenhoff T, Hajeer A, Bernstein R, Xu Q, Wick G. Epitope specificity of anti-heat shock protein 65/60 serum antibodies in atherosclerosis. Arterioscler Thromb Vasc Biol 1997; 17:536-541; PMID:9102173; http://dx.doi.org/10.1161/01.ATV. 17.3.536
25. Noack B, Genco RJ, Trevisan M, Grossi S, Zambon JJ, De Nardin E. Periodontal infections contribute to elevated systemic C-reactive protein level. J Periodontol 2001; 72: 1221-1227; PMID:11577954; http:// dx.doi.org/10.1902/jop.2000.72.9.1221
26. Yoshii S, Tsuboi S, Morita I, Takami Y, Adachi K, Inukai J, Inagaki K, Mizuno K, Nakagaki H. Temporal association of elevated C-reactive protein and periodontal disease in men. J Periodontol 2009; 80:734- 739; PMID:19405826; http://dx.doi.org/10.1902/ jop.2009.080537
27. Loos BG, Craandijk J, Hoek FJ, Wertheim-van Dillen PM, van der Velden U. Elevation of systemic markers related to cardiovascular diseases in the peripheral blood of periodontitis patients. J Periodontol 2000; 71:1528-1534; PMID:11063384; http://dx.doi.org/ 10.1902/jop.2000.71.10.1528
28. Loos BG. Systemic markers of inflammation in periodontitis. J Periodontol 2005; 76:2106-2115; PMID:16277583; http://dx.doi.org/10.1902/jop. 2005.76.11-S.2106
29. Abdallah Ismail N, Ragab SH, Abd Elbaky A, Shoeib AR, Alhosary Y, Fekry D. Frequency of Firmicutes and Bacteroidetes in gut microbiota in obese and normal weight Egyptian children and adults. Arch Med Sci 2011; 7:501-507; PMID:22295035; http://dx. doi.org/10.5114/aoms.2011.23418
30. Fukuda S, Ohno H. Gut microbiome and metabolic diseases. Semin Immunopathol 2014; 36:103-114; PMID:24196453; http://dx.doi.org/10.1007/s00281- 013-0399-z
31. Gargano LM, Hughes JM. Microbial origins of chronic diseases. Annu Rev Public Health 2014; 35:65-82; PMID:24365095; http://dx.doi.org/ 10.1146/annurev-publhealth-032013-182426
32. Wong JM, Esfahani A, Singh N, Villa CR, Mirrahimi A, Jenkins DJ, Kendall CW. Gut microbiota, diet, and heart disease. J AOAC Int 2012; 95:24-30; PMID:22468338; http://dx.doi.org/10.5740/jaoacint.SGE_Wong
33. Turnbaugh PJ, Ley RE, Mahowald MA, Magrini V, Mardis ER, Gordon JI. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 2006; 444:1027-1031; PMID:17183312; http://dx.doi.org/10.1038/nature 05414
34. Turnbaugh PJ, Hamady M, Yatsunenko T, Cantarel BL, Duncan A, Ley RE, Sogin ML, Jones WJ, Roe BA, Affourtit JP, et al. A core gut microbiome in obese and lean twins. Nature 2009; 457:480-484; PMID:19043404; http://dx.doi.org/10.1038/nature 07540
35. Sacks FM, Ornish D, Rosner B, McLanahan S, Castelli WP, Kass EH. Plasma lipoprotein levels in vegetarians: the effect of ingestion of fats from dairy products. JAMA 1985; 254:1337-1341; PMID:4021011; http://dx.doi.org/10.1001/jama. 1985.03360100087019
36. Jenkins DJ, Kendall CW, Marchie A, Jenkins AL, Connelly PW, Jones PJ, Vuksan V. The Garden of Eden-plant based diets, the genetic drive to conserve cholesterol and its implications for heart disease in the 21st century. Comp Biochem Physiol A Mol Integr Physiol 2003; 136:141-151; PMID:14527636; http://dx.doi.org/10.1016/S1095-6433(02)00345-8
37. Bernstein AM, Sun Q, Hu FB, Stampfer MJ, Manson JE, Willett WC. Major dietary protein sources and risk of coronary heart disease in women. Circulation 2010; 122:876-883; PMID:20713902; http://dx.doi. org/10.1161/CIRCULATIONAHA.109.915165
38. Micha R, Wallace SK, Mozaffarian D. Red and processed meat consumption and risk of incident coronary heart disease, stroke, and diabetes mellitus: A systematic review and meta-analysis. Circulation 2010; 121:2271-2283; PMID:20479151; http://dx.doi.org/ 10.1161/CIRCULATIONAHA.109.924977
39. Koeth RA, Wang Z, Levison BS, Buffa JA, Org E, Sheehy BT, Britt EB, Fu X, Wu Y, Li L, et al. Intestinal microbiota metabolism of L-carnitine, a nutrient in red meat, promotes atherosclerosis. Nat Med 2013; 19:576-585; PMID:23563705; http://dx.doi.org/ 10.1038/nm.3145
40. Re RN. Obesity-related hypertension. Ochsner J 2009; 9:133-136; PMID:21603428
41. Lesbros-Pantoflickova D, Corthesy-Theulaz I, Blum AL. Helicobacter pylori and probiotics. J Nutr 2007; 137:812S-8S; PMID:17311980
42. Howell TH. Metchnikoff and prolongation of life. Age Ageing 1988; 17:420-421; PMID:3071118; http://dx.doi.org/10.1093/ageing/17.6.420
43. Food and Agriculture Association on the United Nations, World Health Organization. Health and nutritional properties of probiotics in food including powder milk with live lactic acid bacteria 2001
44. Reid G, Beuerman D, Heinemann C, Bruce AW. Probiotic Lactobacillus dose required to restore and maintain a normal vaginal flora. FEMS Immunol Med Microbiol 2001; 32:37-41; PMID:11750220; http:// dx.doi.org/10.1111/j.1574-695X.2001.tb00531.x
45. Ruszczynski M, Radzikowski A, Szajewska H. Clinical trial: Effectiveness of Lactobacillus rhamnosus (strains E/N, Oxy and Pen) in the prevention of antibioticassociated diarrhoea in children. Aliment Pharmacol Ther 2008; 28:154-161; PMID:18410562; http://dx. doi.org/10.1111/j.1365-2036.2008.03714.x
46. Swidsinski A, Loening-Baucke V, Kirsch S, Doerffel Y. Functional biostructure of colonic microbiota (central fermenting area, germinal stock area and separating mucus layer) in healthy subjects and patients with diarrhea treated with Saccharomyces boulardii. Gastroenterol Clin Biol 2010; 34:S79-92; PMID:20889010; http://dx.doi.org/10.1016/S0399-8320(10)70025-7
47. Guglielmetti S, Mora D, Gschwender M, Popp K. Randomised clinical trial: Bifidobacterium bifidum MIMBb75 significantly alleviates irritable bowel syndrome and improves quality of life-a double-blind, placebo-controlled study. Aliment Pharmacol Ther 2011; 33:1123-1132; PMID:21418261; http://dx. doi.org/10.1111/j.1365-2036.2011.04633.x
48. Francavilla R, Miniello V, Magista AM, De Canio A, Bucci N, Gagliardi F, Lionetti E, Castellaneta S, Polimeno L, Peccarisi L, et al. A randomized controlled trial of Lactobacillus GG in children with functional abdominal pain. Pediatrics 2010; 126:e1445-52; PMID:21078735; http://dx.doi.org/10.1542/peds. 2010-0467
49. Lyra A, Krogius-Kurikka L, Nikkila J, Malinen E, Kajander K, Kurikka K, Korpela R, Palva A. Effect of a multispecies probiotics supplement on quantity of irritable bowel syndrome-related intestinal microbial phylotypes. BMC Gastroenterol 2010; 10:110-230X- 10-110; PMID:20102635; http://dx.doi.org/ 10.1186/1471-230X-10-110
50. Ducrotte P, Sawant P, Jayanthi V. Clinical trial: Lactobacillus plantarum 299v (DSM 9843) improves symptoms of irritable bowel syndrome. World J Gastroenterol 2012; 18:4012-4018; PMID:22912552; http://dx.doi.org/10.3748/wjg.v18.i30.4012
51. McFarland LV, Surawicz CM, Greenberg RN, Fekety R, Elmer GW, Moyer KA, Melcher SA, Bowen KE, Cox JL, Noorani Z, et al. A randomized placebo-controlled trial of Saccharomyces boulardii in combination with standard antibiotics for clostridium difficile disease. JAMA 1994; 271:1913-1918; PMID:8201735; http://dx.doi.org/10.1001/jama.1994.03510480037031
52. Dylag K, Hubalewska-Mazgaj M, Surmiak M, Szmyd J, Brzozowski T. Probiotics in the mechanism of protection against gut inflammation and therapy of gastrointestinal disorders. Curr Pharm Des 2014; 20:1149-55; PMID:23755726; http://dx.doi.org/ 10.2174/13816128113199990422
53. Lee YK, Puong KY. Competition for adhesion between probiotics and human gastrointestinal pathogens in the presence of carbohydrate. Br J Nutr 2002; 88:S101-8; PMID:12215184; http://dx.doi.org/ 10.1079/BJN2002635
54. Nes IF, Diep DB, Havarstein LS, Brurberg MB, Eijsink V, Holo H. Biosynthesis of bacteriocins in lactic acid bacteria. Antonie Van Leeuwenhoek 1996; 70:113-128; PMID:8879403; http://dx.doi.org/ 10.1007/BF00395929
55. Reid G, Younes JA, Van der Mei HC, Gloor GB, Knight R, Busscher HJ. Microbiota restoration: Natural and supplemented recovery of human microbial communities. Nat Rev Microbiol 2011; 9:27-38; PMID:21113182; http://dx.doi.org/10.1038/nrmicro 2473
56. Reid G, Cook RL, Bruce AW. Examination of strains of lactobacilli for properties that may influence bacterial interference in the urinary tract. J Urol 1987; 138:330-335; PMID:3599250
57. Walker WA. Mechanisms of action of probiotics. Clin Infect Dis 2008; 46:S87-91; PMID:18181730; http:// dx.doi.org/10.1086/523335
58. Yan F, Cao H, Cover TL, Whitehead R, Washington MK, Polk DB. Soluble proteins produced by probiotic bacteria regulate intestinal epithelial cell survival and growth. Gastroenterology 2007; 132:562-575; PMID:17258729; http://dx.doi.org/10.1053/j.gastro. 2006.11.022
59. Corthesy B, Gaskins HR, Mercenier A. Cross-talk between probiotic bacteria and the host immune system. J Nutr 2007; 137:781S-90S; PMID:17311975
60. Isolauri E, Sutas Y, Kankaanpaa P, Arvilommi H, Salminen S. Probiotics: Effects on immunity. Am J Clin Nutr 2001; 73:444S-450S; PMID:11157355
61. Ebel B, Lemetais G, Beney L, Cachon R, Sokol H, Langella P, Gervais P. Impact of probiotics on risk factors for cardiovascular diseases. A review. Crit Rev Food Sci Nutr 2014; 54:175-189; PMID:24188267; http://dx.doi.org/10.1080/10408398.2011.579361
62. Crittenden RG, Martinez NR, Playne MJ. Synthesis and utilisation of folate by yoghurt starter cultures and probiotic bacteria. Int J Food Microbiol 2003; 80:217-222; PMID:12423923; http://dx.doi.org/ 10.1016/S0168-1605(02)00170-8
63. Morishita T, Tamura N, Makino T, Kudo S. Production of menaquinones by lactic acid bacteria. J Dairy Sci 1999; 82:1897-1903; PMID:10509247; http:// dx.doi.org/10.3168/jds.S0022-0302(99)75424-X
64. Pompei A, Cordisco L, Amaretti A, Zanoni S, Matteuzzi D, Rossi M. Folate production by Bifidobacteria as a potential probiotic property. Appl Environ Microbiol 2007; 73:179-185; PMID:17071792; http://dx.doi.org/10.1128/AEM.01763-06
65. Ahola AJ, Yli-Knuuttila H, Suomalainen T, Poussa T, Ahlstrom A, Meurman JH, Korpela R. Short-term consumption of probiotic-containing cheese and its effect on dental caries risk factors. Arch Oral Biol 2002; 47:799-804; PMID:12446187; http://dx.doi. org/10.1016/S0003-9969(02)00112-7
66. Caglar E, Cildir SK, Ergeneli S, Sandalli N, Twetman S. Salivary mutans streptococci and lactobacilli levels after ingestion of the probiotic bacterium Lactobacillus reuteri ATCC 55730 by straws or tablets. Acta Odontol Scand 2006; 64:314-318; PMID:16945898; http://dx.doi.org/10.1080/00016350600801709
67. Burton JP, Chilcott CN, Moore CJ, Speiser G, Tagg JR. A preliminary study of the effect of probiotic Streptococcus salivarius K12 on oral malodour parameters. J Appl Microbiol 2006; 100:754-764; PMID:16553730; http://dx.doi.org/10.1111/j.1365- 2672.2006.02837.x
68. Kang MS, Kim BG, Chung J, Lee HC, Oh JS. Inhibitory effect of Weissella cibaria isolates on the production of volatile sulphur compounds. J Clin Periodontol 2006; 33:226-232; PMID:16489950; http://dx.doi.org/10.1111/j.1600-051X.2006.00893.x
69. Di Pierro F, Donato G, Fomia F, Adami T, Careddu D, Cassandro C, Albera R. Preliminary pediatric clinical evaluation of the oral probiotic Streptococcus salivarius K12 in preventing recurrent pharyngitis and/or tonsillitis caused by Streptococcus pyogenes and recurrent acute otitis media. Int J Gen Med 2012; 5:991- 997; PMID:23233809; http://dx.doi.org/10.2147/ IJGM.S38859
70. Teughels W, Durukan A, Ozcelik O, Pauwels M, Quirynen M, Haytac MC. Clinical and microbiological effects of Lactobacillus reuteri probiotics in the treatment of chronic periodontitis: A randomized placebo- controlled study. J Clin Periodontol 2013; 40:1025-1035; PMID:24164569; http://dx.doi.org/ 10.1111/jcpe.12155
71. Shimauchi H, Mayanagi G, Nakaya S, Minamibuchi M, Ito Y, Tamaki K, Hirata H. Improvement of periodontal condition by probiotics with Lactobacillus salivarius WB21: A randomized, double-blind, placebocontrolled study. J Clin Periodontol 2008; 35:897- 905; PMID:18727656; http://dx.doi.org/10.1111/ j.1600-051X.2008.01306.x
72. Hezel M, Weitzberg E. The oral microbiome and nitric oxide homoeostasis. Oral Dis 2013; PMID:23837897
73. Weitzberg E, Lundberg JO. Novel aspects of dietary nitrate and human health. Annu Rev Nutr 2013; 33:129-159; PMID:23642194; http://dx.doi.org/ 10.1146/annurev-nutr-071812-161159
74. Webb AJ, Patel N, Loukogeorgakis S, Okorie M, Aboud Z, Misra S, Rashid R, Miall P, Deanfield J, Benjamin N, et al. Acute blood pressure lowering, vasoprotective, and antiplatelet properties of dietary nitrate via bioconversion to nitrite. Hypertension 2008; 51:784-790; PMID:18250365; http://dx.doi. org/10.1161/HYPERTENSIONAHA.107.103523
75. Kapil V, Milsom AB, Okorie M, Maleki-Toyserkani S, Akram F, Rehman F, Arghandawi S, Pearl V, Benjamin N, Loukogeorgakis S, et al. Inorganic nitrate supplementation lowers blood pressure in humans: Role for nitrite-derived NO. Hypertension 2010; 56:274-281; PMID:20585108; http://dx.doi.org/ 10.1161/HYPERTENSIONAHA.110.153536
76. Ghosh SM, Kapil V, Fuentes-Calvo I, Bubb KJ, Pearl V, Milsom AB, Khambata R, Maleki-Toyserkani S, Yousuf M, Benjamin N, et al. Enhanced vasodilator activity of nitrite in hypertension: Critical role for erythrocytic xanthine oxidoreductase and translational potential. Hypertension 2013; 61:1091-1102; PMID:23589565; http://dx.doi. org/10.1161/HYPERTENSIONAHA.111.00933
77. Kapil V, Haydar SM, Pearl V, Lundberg JO, Weitzberg E, Ahluwalia A. Physiological role for nitratereducing oral bacteria in blood pressure control. Free Radic Biol Med 2013; 55:93-100; PMID:23183324; http://dx.doi.org/10.1016/j.freeradbiomed.2012.11.013
78. Petersson J, Carlström M, Schreiber O, Phillipson M, Christoffersson G, Jägare A, Roos S, Jansson EA, Persson AE, Lundberg JO, et al. Gastroprotective and blood pressure lowering effects of dietary nitrate are abolished by an antiseptic mouthwash. Free Radic Biol Med 2009; 46:1068-1075; PMID:19439233; http://dx.doi.org/10.1016/j.freeradbiomed.2009.01.011
79. Doel JJ, Benjamin N, Hector MP, Rogers M, Allaker RP. Evaluation of bacterial nitrate reduction in the human oral cavity. Eur J Oral Sci 2005; 113:14-19; PMID:15693824; http://dx.doi.org/10.1111/j.1600- 0722.2004.00184.x
80. Hyde ER, Andrade F, Vaksman Z, Parthasarathy K, Jiang H, Parthasarathy DK, Torregrossa AC, Tribble G, Kaplan HB, Petrosino JF, et al. Metagenomic analysis of nitrate-reducing bacteria in the oral cavity: Implications for nitric oxide homeostasis. PLoS One 2014; 9:e88645; PMID:24670812; http://dx.doi.org/ 10.1371/journal.pone.0088645
81. Poirier P, Giles TD, Bray GA, Hong Y, Stern JS, Pi- Sunyer FX, Eckel RH. Obesity and cardiovascular disease: Pathophysiology, evaluation, and effect of weight loss: An update of the 1997 American Heart Association scientific statement on obesity and heart disease from the obesity committee of the council on nutrition, physical activity, and metabolism. Circulation 2006; 113:898-918; PMID:16380542; http://dx.doi. org/10.1161/CIRCULATIONAHA.106.171016
82. Ji YS, Kim HN, Park HJ, Lee JE, Yeo SY, Yang JS, Park SY, Yoon HS, Cho GS, Franz CM, et al. Modulation of the murine microbiome with a concomitant anti-obesity effect by Lactobacillus rhamnosus GG and Lactobacillus sakei NR28. Benef Microbes 2012; 3:13- 22; PMID:22348905; http://dx.doi.org/10.3920/ BM2011.0046
83. McNulty NP, Yatsunenko T, Hsiao A, Faith JJ, Muegge BD, Goodman AL, Henrissat B, Oozeer R, Cools-Portier S, Gobert G, et al. The impact of a consortium of fermented milk strains on the gut microbiome of gnotobiotic mice and monozygotic twins. Sci Transl Med 2011; 3:106; http://dx.doi.org/ 10.1126/scitranslmed.3002701
84. Lee SJ, Bose S, Seo JG, Chung WS, Lim CY, Kim H. The effects of co-administration of probiotics with herbal medicine on obesity, metabolic endotoxemia and dysbiosis: A randomized double-blind controlled clinical trial. Clin Nutr 2013; S0261-5614:00329-4
85. West DB, Delany JP, Camet PM, Blohm F, Truett AA, Scimeca J. Effects of conjugated linoleic acid on body fat and energy metabolism in the mouse. Am J Physiol 1998; 275:R667-72; PMID:9728060
86. Lee HY, Park JH, Seok SH, Baek MW, Kim DJ, Lee KE, Paek KS, Lee Y, Park JH. Human originated bacteria, Lactobacillus rhamnosus PL60, produce conjugated linoleic acid and show antiobesity effects in diet-induced obese mice. Biochim Biophys Acta 2006; 1761:736-744; PMID:16807088; http://dx.doi.org/10.1016/j. bbalip.2006.05.007
87. Lee K, Paek K, Lee HY, Park JH, Lee Y. Antiobesity effect of trans-10,cis-12-conjugated linoleic acid-producing Lactobacillus plantarum PL62 on diet-induced obese mice. J Appl Microbiol 2007; 103:1140-1146; PMID:17897219; http://dx.doi.org/10.1111/j.1365- 2672.2007.03336.x
88. Silveira MB, Carraro R, Monereo S, Tébar J. Conjugated linoleic acid (CLA) and obesity. Public Health Nutr 2007 Oct; 10(10A):1181-6; PMID:17903328; http://dx.doi.org/10.1017/S1368980007000687
89. Hamad EM, Sato M, Uzu K, Yoshida T, Higashi S, Kawakami H, Kadooka Y, Matsuyama H, Abd El- Gawad IA, Imaizumi K. Milk fermented by Lactobacillus gasseri SBT2055 influences adipocyte size via inhibition of dietary fat absorption in Zucker rats. Br J Nutr 2009; 101:716-724; PMID:18684338; http:// dx.doi.org/10.1017/S0007114508043808
90. Takemura N, Okubo T, Sonoyama K. Lactobacillus plantarum strain no. 14 reduces adipocyte size in mice fed high-fat diet. Exp Biol Med (Maywood) 2010; 235:849-856; PMID:20558839; http://dx.doi.org/ 10.1258/ebm.2010.009377
91. Grundy SM. Promise of low-density lipoprotein-lowering therapy for primary and secondary prevention. Circulation 2008; 117:569-73; PMID:18227397; http://dx.doi.org/10.1161/CIRCULATIONAHA.107. 720300
92. Guo Z, Liu XM, Zhang QX, Liu XM, Zhang QX, Shen Z, Tian FW, Zhang H, Sun ZH, Zhang HP, et al. Influence of consumption of probiotics on the plasma lipid profile: A meta-analysis of randomised controlled trials. Nutr Metab Cardiovasc Dis 2011; 21:844-850; PMID:21930366; http://dx.doi.org/ 10.1016/j.numecd.2011.04.008
93. Kimoto H, Ohmomo S, Okamoto T. Cholesterol removal from media by lactococci. J Dairy Sci 2002; 85:3182-3188; PMID:12512591; http://dx.doi.org/ 10.3168/jds.S0022-0302(02)74406-8
94. Lye HS, Rahmat-Ali GR, Liong MT. Mechanisms of cholesterol removal by lactobacilli under conditions that mimic the human gastrointestinal tract. Int Dairy J 2010; 20:169-175; http://dx.doi.org/10.1016/j. idairyj.2009.10.003
95. Doublet A, Robert V, Vedie B, Rousseau-Ralliard D, Reboulleau A, Grynberg A, Paul JL, Fournier N. Contrasting effects of arachidonic acid and docosahexaenoic acid membrane incorporation into cardiomyocytes on free cholesterol turnover. Biochim Biophys Acta 2014 Oct; 1842(10):1413-21
96. Tok E, Aslim B. Cholesterol removal by some lactic acid bacteria that can be used as probiotic. Microbiol Immunol 2010 May; 54(5):257-64
97. Wall R, Marques TM, O'Sullivan O, Ross RP, Shanahan F, Quigley EM, Dinan TG, Kiely B, Fitzgerald GF, Cotter PD, et al. Contrasting effects of Bifidobacterium breve NCIMB 702258 and Bifidobacterium breve DPC 6330 on the composition of murine brain fatty acids and gut microbiota. Am J Clin Nutr 2012 May; 95(5):1278-87; PMID:22492373; http://dx. doi.org/10.3945/ajcn.111.026435
98. Maekawa M, Takashima N, Matsumata M, Ikegami S, Kontani M, Hara Y, Kawashima H, Owada Y, Kiso Y, Yoshikawa T, et al. Arachidonic acid drives postnatal neurogenesis and elicits a beneficial effect on prepulse inhibition, a biological trait of psychiatric illnesses. PLoS One 2009; 4(4):e5085; PMID:19352438; http://dx.doi.org/10.1371/journal. pone.0005085
99. Yurko-Mauro K, McCarthy D, Rom D, Nelson EB, Ryan AS, Blackwell A, Salem N Jr, Stedman M. MIDAS Investigators. Beneficial effects of docosahexaenoic acid on cognition in age-related cognitive decline. Alzheimers Dement 2010 Nov; 6(6):456-64; http://dx.doi.org/10.1016/j.jalz.2010.01.013
100. Pavlovic N, Stankov K, Mikov M. Probiotics-interactions with bile acids and impact on cholesterol metabolism. Appl Biochem Biotechnol 2012; 168:1880- 1895; PMID:23054820; http://dx.doi.org/10.1007/ s12010-012-9904-4
101. Elkins CA, Moser SA, Savage DC. Genes encoding bile salt hydrolases and conjugated bile salt transporters in Lactobacillus johnsonii 100-100 and other Lactobacillus species. Microbiology 2001; 147:3403-3412; PMID:11739773
102. Kumar M, Nagpal R, Kumar R, Hemalatha R, Verma V, Kumar A, Chakraborty C, Singh B, Marotta F, Jain S, et al. Cholesterol-lowering probiotics as potential biotherapeutics for metabolic diseases. Exp Diabetes Res 2012; 2012:902917; PMID:22611376; http:// dx.doi.org/10.1155/2012/902917
103. Begley M, Hill C, Gahan CG. Bile salt hydrolase activity in probiotics. Appl Environ Microbiol 2006 Mar; 72(3):1729-38; PMID:16517616; http://dx.doi. org/10.1128/AEM.72.3.1729-1738.2006
104. Joyce SA, MacSharry J, Casey PG, Kinsella M, Murphy EF, Shanahan F, Hill C, Gahan CG. Regulation of host weight gain and lipid metabolism by bacterial bile acid modification in the gut. Proc Natl Acad Sci USA 2014 May 20;111 (20):7421-6; PMID:24799697; http://dx.doi.org/ 10.1073/pnas.1323599111
105. Sayin SI, Wahlström A, Felin J, Jäntti S, Marschall HU, Bamberg K, Angelin B, Hyötyläinen T, Orešić M, Bäckhed F. Gut microbiota regulates bile acid metabolism by reducing the levels of tauro-β-muricholic acid, a naturally occurring FXR antagonist. Cell Metab 2013 Feb 5; 17(2):225-35; http://dx.doi. org/10.1016/j.cmet.2013.01.003
106. Jones ML, Tomaro-Duchesneau C, Prakash S. The gut microbiome, probiotics, bile acids axis, and human health. Trends Microbiol 2014 Jun; 22 (6):306-8; PMID:24836108; http://dx.doi.org/ 10.1016/j.tim.2014.04.010
107. Degirolamo C, Rainaldi S, Bovenga F, Murzilli S, Moschetta A. Microbiota modification with probiotics induces hepatic bile acid synthesis via downregulation of the Fxr-Fgf15 axis in mice. Cell Rep 2014 Apr 10; 7(1):12-8; PMID:24656817; http://dx.doi.org/ 10.1016/j.celrep.2014.02.032
108. Jones ML, Martoni CJ, Prakash S. Cholesterol lowering and inhibition of sterol absorption by Lactobacillus reuteri NCIMB 30242: A randomized controlled trial. Eur J Clin Nutr 2012; 66:1234-1241; PMID:22990854; http://dx.doi.org/10.1038/ejcn. 2012.126
109. Egan BM, Li J, Qanungo S, Wolfman TE. Blood pressure and cholesterol control in hypertensive hypercholesterolemic patients: National health and nutrition examination surveys 1988-2010. Circulation 2013; 128:29-41; PMID:23817481; http://dx.doi. org/10.1161/CIRCULATIONAHA.112.000500
110. Dong JY, Szeto IM, Makinen K, Gao Q, Wang J, Qin LQ, Zhao Y. Effect of probiotic fermented milk on blood pressure: A meta-analysis of randomised controlled trials. Br J Nutr 2013; 110:1188- 1194; PMID:23823502; http://dx.doi.org/ 10.1017/S0007114513001712
111. Gonzalez-Gonzalez C, Gibson T, Jauregi P. Novel probiotic-fermented milk with angiotensin I-converting enzyme inhibitory peptides produced by Bifidobacterium bifidum MF 20/5. Int J Food Microbiol 2013; 167:131-137; PMID:24135669; http://dx.doi. org/10.1016/j.ijfoodmicro.2013.09.002
112. Yeo SK, Liong MT. Angiotensin I-converting enzyme inhibitory activity and bioconversion of isoflavones by probiotics in soymilk supplemented with prebiotics. Int J Food Sci Nutr 2010; 61:161- 181; PMID:20085504; http://dx.doi.org/10.3109/ 09637480903348122
113. Yan F, Polk DB. Probiotic bacterium prevents cytokineinduced apoptosis in intestinal epithelial cells. J Biol Chem 2002; 277:50959-50965; PMID:12393915; http://dx.doi.org/10.1074/jbc.M207050200
114. Zhao B, Sun G, Feng G, Duan W, Zhu X, Chen S, Hou L, Jin Z, Yi D. Carboxy terminus of heat shock protein (HSP) 70-interacting protein (CHIP) inhibits HSP70 in the heart. J Physiol Biochem 2012; 68:485- 491; PMID:22456997; http://dx.doi.org/10.1007/ s13105-012-0161-3
115. Lam V, Su J, Koprowski S, Hsu A, Tweddell JS, Rafiee P, Gross GJ, Salzman NH, Baker JE. Intestinal microbiota determine severity of myocardial infarction in rats. FASEB J 2012; 26:1727-1735; PMID:22247331; http://dx.doi.org/10.1096/fj.11- 197921
116. Go AS, Mozaffarian D, Roger VL, Benjamin EJ, Berry JD, Blaha MJ, Dai S, Ford ES, Fox CS, Franco S, et al. American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics-2014 update: A report from the American Heart Association. Circulation 2014; 129:e28-e292; PMID:24352519; http://dx.doi.org/ 10.1161/01.cir.0000441139.02102.80
117. Gan XT, Ettinger G, Huang CX, Burton JP, Haist JV, Rajapurohitam V, Sidaway JE, Martin G, Gloor GB, Swann JR, et al. Probiotic administration attenuates myocardial hypertrophy and heart failure following myocardial infarction in the rat. Circ Heart Fail 2014; 7:491-9; PMID:24625365; http://dx.doi.org/ 10.1161/CIRCHEARTFAILURE.113.000978
118. Sanders ME. Probiotics: Definition, sources, selection, and uses. Clin Infect Dis 2008; 46:S58-61; PMID:18181724; http://dx.doi.org/10.1086/ 523341
119. Metra M, Giubbini R, Nodari S, Boldi E, Modena MG, Dei Cas L. Differential effects of beta-blockers in patients with heart failure: A prospective, randomized, double-blind comparison of the long-term effects of metoprolol versus carvedilol. Circulation 2000; 102:546-551; PMID:10920067; http://dx.doi.org/ 10.1161/01.CIR.102.5.546
120. Hussey LC, Hardin S, Blanchette C. Outpatient costs of medications for patients with chronic heart failure. Am J Crit Care 2002; 11:474-478; PMID:12233973